Dutasteride |
|
| Name: | Dutasteride |
| Synonyms | (5alpha,17beta)-N-{2,5-Bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide |
| Molecular Structure: | |
| Molecular Formula | C27H30F6N2O2 |
| Molecular Weight: | 528.53 |
| Cas. No.: | 164656-23-9 |
| EINECS: | |
| Standard: | Enterprise standard |
| Description: | |
| Dutasteride is a derivative of finasteride. Dutasteride is a 5-alpha-reductase inhibitor which inhibits the conversion of testosterone into dihydrotestosterone (DHT). It is FDA approved for the treatment of benign prostatic hyperplasia (BPH) and is prescribed off-label for the treatment of male pattern baldness (MPB). Dutasteride is manufactured by GlaxoSmithKline and marketed under the brand name Avodart. | |
Copyright(C)2017-2018, Pharhome International Limited, All Rights Reserved.